FindTrial
Sign In

Comparison of effectiveness between 7%,3%,0.9% saline nebulization as treatment option for moderate to severe bronchiolitis in children aged 1 month to 2 year who are admitted in medical college Aurangabad.

Comparison of Efficacy between 7% , 3% and 0.9% Saline Solution in the Management of Moderate to Severe Bronchiolitis in Children aged 1 to 24 months admitted in a Tertiary Care Hospital - A Multiarm Single Blinded Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089869
Enrollment
96
Registered
2025-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J210- Acute bronchiolitis due to respiratory syncytial virus

Interventions

Intervention1: 7 percent saline: Nebulization of 2.5 mL 7 % hypertonic saline 6 hourly till 5 days of admission Intervention2: 0.9 percent saline: nebulization of 2.5 mL 0.9 % hypotonic saline 6 hourl

Sponsors

MD ABDUL AZAM MD NAEEM INAMDAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Children between 1 to 24 months of age with moderate to severe bronchiolitis admitted in the Paediatric Ward and PICU.

Exclusion criteria

Exclusion criteria: 1. Children with Cardiac Diseases. 2. Children with Major Congenital Anomaly. 3. Children already treated outside the hospital. 4. Children whose Parents will not give consent.

Design outcomes

Primary

MeasureTime frame
Clinical improvement Reduction in hospital stay Timepoint: 5 days of nebulization—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactMD ABDUL AZAM MD NAEEM INAMDAR

GOVERNMENT MEDICAL COLLEGE AURANGABAD

pmorekhaire@rediffmail.com9850947118

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026